Author:
Dai Yanmei,Liu Dongmin,Xin Yanjie,Li Yuchong,Wang Dandan,He Baochun,Zeng Xu,Li Jiaping,Jia Fucang,Jiang Huijie
Funder
Natural Science Foundation of Guangdong Province
Key Technologies Research and Development Program
National Key Research and Development Program of China
National Natural Science Foundation of China
Subject
Radiology, Nuclear Medicine and imaging
Reference28 articles.
1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021
2. Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification;Chidambaranathan-Reghupaty,2021
3. Expert consensus on transarterial chemoembolization refractoriness and subsequent therapies in hepatocellular carcinoma;Zhonghua Nei Ke Za Zhi,2022
4. Standardization for diagnosis and treatment of hepatocellular carcinoma (2022 edition];Zhonghua Gan Zang Bing Za Zhi,2022
5. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases;Marrero;Hepatology,2018